Finch Therapeutics Group, Inc.
SEC CIK 1733257 · FNCH · last insider filing 2024-06-10
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Smisek Jeffrey A | Director | filed 2021 - 2024 |
| Ferrante Domenic J | Director | filed 2021 - 2023 |
| Shumway Chris | Director | filed 2021 - 2023 |
| Graf Susan E | Director | filed 2021 - 2023 |
| Haft Nicholas | Director | filed 2021 - 2023 |
| Lange Christian H. | Director | filed 2021 - 2023 |
| Hamood Samuel A | Director | filed 2021 - 2022 |
| Viney Joanne L. | Director | filed 2021 - 2022 |
| Crestovo Investor LLC | Director | filed 2021 - 2021 |
| Smith Mark Burnham | Director · Chief Executive Officer | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Blischak Matthew P. | Chief Executive Officer | filed 2023 - 2023 |
| Thibault Lance E | Chief Financial Officer | filed 2023 - 2023 |
| Blaustein Marc | Chief Operating Officer | filed 2021 - 2023 |
| Vittiglio Joseph | General Counsel and Secretary | filed 2021 - 2022 |
| Perry Gregory D | Chief Financial Officer | filed 2021 - 2022 |
| Kassam Zain | Chief Medical Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.